Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Global Ascension Studios Announces Production of Groundbreaking Documentary: "The Man You Don’t Know"
-
Coherent Expands Optical Communications Test Portfolio with New WaveShaper and WaveMaker Instruments
-
Nordic American Tankers Ltd (NYSE: NAT) – Shareholder/Investor conference Thursday September 12, 2024
-
SalMar - Extension of Commercial Paper
-
Vow ASA: Chairman of the Board
-
Net Asset Value(s)
-
HSBC Bank Plc - Form 8.5 (EPT/RI) - Keywords Studios plc
-
IGI Announces Publication in Nature Cancer on ISB 2001, IGI's Innovative Trispecific Antibody for Relapsed/Refractory Multiple Myeloma
-
IGI Announces Publication in Nature Cancer on ISB 2001, IGI's Innovative Trispecific Antibody for Relapsed/Refractory Multiple Myeloma
-
SOLASTA Bio Completes $14m Series A to Accelerate Nature-Inspired Crop Protection
-
Form 8.5 (EPT/RI) - musicMagpie Plc
-
Form 8.5 (EPT/RI) - NewRiver REIT Plc
-
Form 8.5 (EPT/RI) - Touchstone Exploration Inc.
-
Result of the auction of treasury bills on 11 September 2024
-
Stabilization Notice - Pre Stab Notice - Azelis Finance NV
-
Dimensional Fund Advisors Ltd. : Form 8.3 - VIRGIN MONEY UK PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - SEGRO plc - Ordinary Shares
-
Form 8.5 (EPT/RI)-Eckoh plc
-
Dimensional Fund Advisors Ltd. : Form 8.3 - RIGHTMOVE PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - CENTAMIN PLC - Ordinary Shares
-
Dimensional Fund Advisors Ltd. : Form 8.3 - ANGLOGOLD ASHANTI PLC - Ordinary Shares
-
OKX Ventures Partner Jeff Ren Moderates Panel on APAC's Investment Potential at Aptos Experience
-
LinkGevity Secures Place in Prestigious SPACE-H Accelerator Program
-
OKX Ventures Partner Jeff Ren Moderates Panel on APAC's Investment Potential at Aptos Experience
-
Vaisala acquires Speedwell Climate to help organizations mitigate weather-related financial risks
-
Oxford-Harrington Rare Disease Centre Appoints Influential UK Leader in Health Innovation Policy, Baroness Nicola Blackwood, to its Advisory Council
-
Net Asset Value(s)
-
Marimekko Capital Markets Day 2024
-
Changes in the Management Board of Nordic Fibreboard AS subsidiary
-
Crédit Agricole Assurances announces the success of its previously launched Tender Offers, their Final Acceptance Amount and the Results
-
Inside information: Orion upgrades full-year outlook for 2024
-
Syensqo - Participation notification by BlackRock Inc.
-
Opus Security Elevates Vulnerability Management With its AI-Powered Multi-Layered Prioritization Engine
-
News from INVL Technology managed companies: Novian had revenue of EUR 16.4 million in the first half of 2024
-
Vow ASA: Notification of major shareholding and mandatory notification of trade
-
Ecologic Processing Association Agreement signed in connection with former Hanes Gold Mine, Romania & Operational Updates
-
Transaction in own shares
-
Michelin : Disclosure of trading in own shares - September 11, 2024
-
Sampo plc’s share buybacks 10 September 2024
-
BGHL (GBP): NAV(s)
-
BW Energy: Company Presentation Pareto Securities' Energy Conference 2024
-
BGHL (EUR): NAV(s)
-
BW Offshore: Company presentation
-
Dupixent® (dupilumab) Phase 3 Trial Confirms Significant Improvements in Itch and Hives for Patients with Chronic Spontaneous Urticaria (CSU)
-
Press Release: Dupixent phase 3 study confirms significant improvements in itch and hives for patients with CSU
-
Bioversys Announces Strategic Investment From GIBF2 and Launch of BV100 Clinical Program in China
-
Press Release: Dupixent is the first and only biologic to achieve significant improvements in disease remission and symptoms in bullous pemphigoid positive pivotal study
-
Start of Day Message
-
IBA’s joint venture PanTera secures EUR 93 million in oversubscribed Series A round to accelerate global actinium-225 production
-
TGS Presentation at Pareto Securities Energy Conference 2024
